Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04824495
NCT04824495UnknownNot Applicable

Evaluation of Inflammatory Cytokines During COVID-19

University of Vienna1 site in 1 country100 target enrollmentStarted: January 7, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Locations
1
Primary Endpoint
Cytokine level in context with clinical parameters
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.

Detailed Description

In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory cyokines and microvesicles at day 1, 5, 9 and 13 during hospitalisation and are interpreted in the context of clinical parameters.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age > 18 years
  • •Confirmation of acute SARS-CoV2 infection
  • •Ability to provide informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Cytokine level in context with clinical parameters

Time Frame: 2 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Daniela Gompelmann

Prof. Dr. med.

University of Vienna

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
INFLAMmatory BiomarkErs in COVID-19 Participants and Severity of DiseaseCOVID-19
NCT05175846Trinitas Global, LLC60
Completed
Not Applicable
Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis PatientsCovid19Hemodialysis ComplicationInflammatory Response
NCT04685447Universita degli Studi di Genova30
Completed
Not Applicable
Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19Covid19Kidney DiseasesInflammationSARS-CoV Infection
NCT04706533University of Michigan3,402
Completed
Phase 3
Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19COVID-19
NCT04667780Ayub Teaching Hospital102
Completed
Not Applicable
International Study of Inflammation in COVID-19Covid19Outcome, FatalInflammationAcute Kidney InjuryRespiratory Failure
NCT04818866University of Michigan4,463